Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound fructose electrolyte injection for postoperative bone trauma fluid replacement (Phase II)
CTR20250813Phase 2Active
- Sponsor
- Zhizhen Biology
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of compound fructose electrolyte injection in Postoperative state after bone trauma surgery, sponsored by Zhizhen Biology. Started Mar 2025; status: active.
02
Drugs
compound fructose electrolyte injection
03
Conditions
Postoperative state after bone trauma surgery
Beyond the preview
Go deeper on CTR20250813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250813.